Cancer patient denied treatment until it was too late

For nearly three years, Eric Tennant endured chemotherapy infusions, rounds of radiation, biopsies, and hospitalizations that left him weak and depleted.

"It's good to be home," he said after one hospital stay in early June, "yet I'm tired and ready to get on with things."

In 2023, Tennant, of Bridgeport, West Virginia, was diagnosed with cholangiocarcinoma, a rare cancer of the bile ducts that had spread throughout his body.

None of the initial treatments prescribed by his doctors had eradicated the cancer. But a glimmer of hope came in early 2025, when Tennant was recommended for histotripsy, a relatively new procedure that would use ultrasound waves to target, and potentially destroy, the largest tumor in his body — in his liver.

"My dad was a little nervous because it was something new, but it definitely gave us some hope that he would be around a little bit longer," said Tennant's daughter, Amiya.

There was just one hitch: His insurer wouldn't pay for it.

Tennant, 58, died of cancer on Sept. 17. His story illustrates how a bureaucratic process called prior authorization can devastate patients and their families.

It's infeasible to count the people harmed by this overwhelmingly unpopular practice, which, by delaying or denying care, helps drive health insurers' profits. No government agency or private group tracks such data.

That said, KFF Health News has heard from hundreds of patients in recent years who claim that they or someone in their family has been harmed by prior authorization. More than 1 in 4 physicians surveyed by the American Medical Association last December said that prior authorization had led to a serious adverse event for a patient in their care. And 8% responded that prior authorization led to a disability, birth defect or death.

In June, the Trump administration announced a pledge, signed by dozens of private insurers, to streamline prior authorization, which often requires patients or their medical teams to ask insurers for permission before proceeding with many types of care. It remains unclear when patients can expect to see improvement.

The commitments "depend on the full cooperation of the private insurance sector" and will "take time to achieve their full effect," said Andrew Nixon, a spokesperson for the Department of Health and Human Services. But the pledge exists, he said, "to prevent tragic deaths like Eric's from occurring at the hands of an inefficient system."

Chris Bond, a spokesperson for AHIP, a health insurance industry trade group, said he could not speak to any specific insurer's prior authorization policies. Broadly, though, he said prior authorization "acts as a guardrail" to make sure medicines and treatments are not used inappropriately.

At the same time, he said, insurers recognize that patients can be frustrated when their doctor-recommended care is denied. That's why "there is a dedicated effort across the industry to make the process more straightforward, faster, and simpler for patients and providers," Bond said.

In the meantime, the process continues to take its toll on people like Eric Tennant, whose grave diagnoses often require expensive health care services.

"Eric is gone," his widow, Becky, said. "He's not coming back."

Tennant was a safety instructor for the West Virginia Office of Miners' Health Safety and Training and insured by the state's Public Employees Insurance Agency, which contracts with UnitedHealthcare to administer benefits for state employees, their spouses, and dependents.

In February and March, UnitedHealthcare, the Public Employees Insurance Agency, and an outside reviewer issued a series of denials that concluded Eric's benefits would not cover histotripsy, claiming the treatment was not medically necessary. Becky Tennant estimated the procedure would cost the family about $50,000 out-of-pocket.

Although the treatment wasn't guaranteed to work, it was worth a shot, the Tennants thought, so they considered withdrawing money from their retirement savings. But then, in May, after KFF Health News and NBC News posed a series of questions to UnitedHealthcare and the Public Employees Insurance Agency about Eric's case, the agency reversed course. PEIA decided to cover his treatment.

Notably, the agency contacted KFF Health News about the approval hours before it notified the Tennant family of the decision.

But the approval came too late. Eric was hospitalized in late May and prescribed medication that prevented him from undergoing histotripsy at that time. His family held out hope that his health would improve and he would qualify for the procedure that summer.

In July, they took a family vacation to Marco Island, Florida. It would be their last. Two days after they returned home, a scan revealed Eric's cancer had continued to spread. Histotripsy was out of the question.

"I'm sad for what we will miss out on," Becky said. "I'm sad at the unfairness of it."

She said if Eric had been able to undergo histotripsy in February, as originally recommended by his doctor, it might have destroyed the tumor in his liver that ultimately killed him.

"We'll never know. That's the thing. Any lawyer for the insurance will say, 'Well, you don't know it would have helped.' No. You took that chance away from us," she said.